Apple Watch Expected to Feature Blood Glucose Monitoring in Two Years, Analyst’s Product Launch Roadmap Unveils Details, Uncertainty Surrounds ‘Ultra’ Variant

Bringing innovative features to the Apple Watch has presented significant challenges for Apple, especially considering a reported 19% decline in shipments in Q4 2024. A major hurdle lies in the integration of advanced health sensors within the already compact device. Despite Apple’s notable progress in health technology, the implementation of blood glucose monitoring remains elusive. However, a recent analysis suggests that this sought-after feature may become available in about two years.

Uncertain Roadmap for Blood Glucose Monitoring on Future Apple Watches

Insight from GF Securities analyst Jeff Pu indicates that while blood glucose monitoring is anticipated two years from now, there are no concrete indications from supply chain resources to confirm its arrival in the upcoming Apple Watch Series 13. This raises the possibility that the projected timeline may be speculative rather than based on verified developments. In addition to this, Pu’s timeline points to the launch of more affordable Apple Vision Air smart glasses in 2027, hinting at an exciting year ahead for the tech titan.

Contrary to these predictions, a report from 2023 suggested that the implementation of blood glucose monitoring could still be several years off—estimates placed it as far away as seven years. Renowned tech journalist Mark Gurman from Bloomberg noted that, as of 2023, non-invasive glucose monitoring had reached a ‘proof of concept’ stage but that significant obstacles remain, particularly regarding the size of the necessary sensors, which currently cannot be compacted enough for wrist-worn devices. Consequently, the latest Apple Watch Series 10 continues to utilize functionalities introduced in earlier versions, even as rumors of prototypes featuring novel sensors persist.

Apple Product Timeline by Jeff Pu, GF Securities Hong Kong pic.twitter.com/jEIGMi7Twv

— Jukan Choi (@Jukanlosreve) June 15, 2025

The specific details regarding this promising hardware remain undetermined, and the prototype lacks a means for software interaction at this stage, leaving us in a state of uncertainty. Pu’s product roadmap does not specify whether any models within the Apple Watch Ultra line will incorporate the blood glucose monitoring feature, nor does it provide supply chain evidence verifying Apple’s ambitions in this area. Thus, it is prudent to approach these forecasts with caution and remain alert for future developments.

Source & Images